Commentary and opinion on current medical issues by a practicing primary-care physician.
Tuesday, July 31, 2007
Pfizer: Going to the dogs
Having had setbacks with torcetrapib and Exubera, and with generic competition to Norvasc and Lipitor, Pfizer is putting more emphasis into animal drugs.